Literature DB >> 12552975

Is tumor size a prognostic indicator for gastric carcinoma?

Takashi Yokota1, Shuichi Ishiyama, Toshihiro Saito, Shin Teshima, Yasuo Yamada, Kazutsugu Iwamoto, Michinori Takahashi, Katsuyuki Murata, Hidemi Yamauchi.   

Abstract

BACKGROUND: Retrospective studies using multivariate analysis of clinical and pathological features in gastric cancer have identified a number of high-risk, independent prognostic factors. In these clinical features, tumor size can be measured easily before or during the operation without the requirement of any special equipment, but its prognostic value in patients with gastric cancer is unclear. The aim of this study was to review the experience at our institution of gastric adenocarcinoma to determine the influence of tumor size on outcome. PATIENTS AND METHODS: Between January 1985 and December 1995, 697 patients with gastric adenocarcinoma underwent resection of the stomach at the Department of Surgery, Sendai National Hospital, Japan. Data on age, gender, tumor location, structure and size, evidence of local invasion, and type of operation performed for each patient were obtained. The sizes of tumors were derived from measurements made in fresh resected specimens. The patients were divided into three groups: 102 patients with tumors of less than 2 cm in diameter, 392 patients with tumors of 2-7 cm in diameter, and 203 patients with tumors of more than 7 cm in diameter.
RESULTS: In these three groups, there were statistical differences in tumor location, macroscopic type, depth of invasion, lymph node metastasis, histological type, lymphatic invasion, vascular invasion and cancer-stromal relationship. Patients with larger tumors had more invasion into the gastric wall in terms of depth of invasion and more frequent lymph node metastasis than did patients with smaller tumors. Histologically, diffuse, scirrhous-type was more common in the larger tumor group. The frequency of lymphatic and vascular permeation in the larger tumor group was higher than that in the other groups. The 5-year survival rates according to tumor size were 94.3% in cases of tumors of less than 2 cm, 75.1% in cases of tumors of 2-7 cm, and 26.3% in cases of tumors of more than 7 cm. Multivariate analysis revealed that the prognosis of gastric cancer patients was affected most by depth of invasion, followed by lymph node metastasis and tumor location. Tumor size is not an independent prognostic factor.
CONCLUSION: In conclusion, according to the results of univariate analysis, tumor size is clinically a predictor of survival of patients with gastric cancer. In multivariate analysis, however, it is not an independent factor, and the presence of lymph node metastasis, depth of invasion and tumor location are more important than tumor size.

Entities:  

Mesh:

Year:  2002        PMID: 12552975

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  29 in total

1.  The efficacy of gastrectomy for large gastric cancer.

Authors:  Osamu Kobayashi; Akira Tsuburaya; Takaki Yoshikawa; Tomohiko Osaragi; Hitoshi Murakami; Tatsuya Yoshida; Motonori Sairenji
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

2.  Prognostic significance of host- and tumor-related factors in patients with gastric cancer.

Authors:  Yasuhiko Mohri; Kouji Tanaka; Masaki Ohi; Takeshi Yokoe; Chikao Miki; Masato Kusunoki
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

3.  Identification of a DNA methylation marker that detects the presence of lymph node metastases of gastric cancers.

Authors:  Yasuyuki Shigematsu; Tohru Niwa; Satoshi Yamashita; Hirokazu Taniguchi; Ryoji Kushima; Hitoshi Katai; Seiji Ito; Tetsuya Tsukamoto; Masao Ichinose; Toshikazu Ushijima
Journal:  Oncol Lett       Date:  2012-05-09       Impact factor: 2.967

4.  Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma.

Authors:  Dong Yi Kim; Kyeung Won Seo; Jae Kyoon Joo; Young Kyu Park; Seong Yeob Ryu; Hyeong Rok Kim; Young Jin Kim; Shin Kon Kim
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

5.  Prognostic value of tumor size in gastric cancer: an analysis of 2,379 patients.

Authors:  Pengtao Guo; Yangming Li; Zhi Zhu; Zhe Sun; Chong Lu; Zhenning Wang; Huimian Xu
Journal:  Tumour Biol       Date:  2013-01-15

6.  Clinicopathological features of early gastric cancer with duodenal invasion.

Authors:  Tsutomu Namikawa; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

7.  Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer.

Authors:  Guanzhen Yu; JieJun Wang; Ying Chen; Xi Wang; Jun Pan; Qiang Li; Keping Xie
Journal:  Clin Exp Metastasis       Date:  2008-06-06       Impact factor: 5.150

8.  Does tumor size have an impact on gastric cancer? A single institute experience.

Authors:  Kyong Hwa Jun; Hun Jung; Jong Min Baek; Hyung Min Chin; Woo Bae Park
Journal:  Langenbecks Arch Surg       Date:  2008-09-13       Impact factor: 3.445

9.  Clinicopathological properties of the superficial spreading type early gastric cancer.

Authors:  Tsutomu Namikawa; Hiroyuki Kitagawa; Jun Iwabu; Takehiro Okabayashi; Takeki Sugimoto; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  J Gastrointest Surg       Date:  2009-10-10       Impact factor: 3.452

10.  Clinicopathologic characteristics and outcomes of surgery of middle-third gastric cancer.

Authors:  Jingyu Deng; Han Liang; Rupeng Zhang; Dan Sun; Yi Pan; Li Zhang; Xishan Hao
Journal:  Tumour Biol       Date:  2012-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.